Nuclear receptors in lipid metabolism: Targeting the heart of dyslipidemia

A study was conducted on the important role played by nuclear hormone receptors in lipid and inflammatory homeostasis, which forms the basis for future therapies. Results show that the liver X receptor (LXR) and peroxisome proliferator-activated receptor (PPAR) are made attractive molecular targets for managing lipid-related diseases as a result of glucose homeostasis and inflammation.